Rani Therapeutics (Nasdaq: RANI) Makes Nasdaq Top Gainer on $1.085 Billion Pharma Collaboration News
The stock makes the Nasdaq top gainer list on a massive $1.085 Billion pharma deal. The stock is trading at $1.6300, up ...
Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral formulation leveraging RaniPill technology: Tokyo Wednesday, October 22, 2025, 12:00 Hrs [IST] Ch ...
Q3 2025 Earnings Call Transcript October 21, 2025 Northrop Grumman Corporation beats earnings expectations. Reported EPS is ...
For 3 months ended September 30, Third Avenue Value Fund returned 11.85%, as compared to the MSCI World Index, which returned ...
Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up ...
The Wildcats reached the Elite Eight in year one of the Jerome Tang tenure, advanced to the NIT in the second season and ...
In the most recent quarter, Wynn’s shares increased 37.3% following strong second quarter results and better-than-expected ...
Q3 2025 Earnings Call Transcript October 21, 2025 Philip Morris International Inc. beats earnings expectations. Reported EPS ...
For five years, Greg McDermott and the Creighton Bluejays were anchored by Ryan Kalkbrenner, one of the best defensive ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results